Biotech firm launches low cost tuberculosis test in India

BIOTECH company Epistem Holdings has announced the commercial launch of its Genedrive tuberculosis (TB) and antibiotic resistance test in India.

With its Indian commercialisation partner, Xcelris Labs, the company hopes to target Genedrive at private clinical labs in the country, providing a rapid point-of-care testing service for TB.

Previously, this diagnostics technique has only been available through large hospital laboratories in the country.

Epistem hopes that the low system cost, ease of u... You can carry on reading for free, but you have reached the maximum number of pages an unregistered user can view. To register for an account, click here or login below...